China gives conditional approval for Pfizer COVID pill: drug regulator

China on Saturday said it had given "conditional" approval for Pfizer's COVID-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.

source https://medicalxpress.com/news/2022-02-china-conditional-pfizer-covid-pill.html